Analysis of human interindividual and racial differeness of drug response and metabolism : Approach by the method of diagnosis by gene analysis
药物反应和代谢的人类个体和种族差异分析:基因分析诊断方法
基本信息
- 批准号:05454153
- 负责人:
- 金额:$ 4.29万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Mephenytoin was administered to seven healthy volunteers of Japanese, and those were phenotyped extensive(EM)and poor metabolizers(PM)of mephenytoin 4'-hydroxylation.Six subjects were judged as EM,and one as PM.Twelve liver microsomal samples of Japanese and five samples of Caucasian were also phenotyped EM and PM by measuring R-and S-mephenytoin 4'-hydroxylation.Nine Japanese and five Caucasian subjects were judged as EM and three Japanese were PM.Genomic DNAs were isolated from nine EM and four PM,and DNA sequences were analyzed and the sequences of putative mephenytoin 4'-hydroxylases (CYP2C forms) were compared between EM and PM.No difference was observed on the sequences of CYP2C9/18 between EM and PM.Anucleotide substitution was detected in the sequence of exon 4 of CYP2C19 in PM,phenotyped in vivo.Another mutation was detected in the sequense of intron 4 just before exon 5 of CYP2C19 in PM,phenotyped in vitro.In either case, CYP2C19 does not express in PM livers, Metabolism of diazepam was studied in vitro by using liver microsomes obtained from EM and PM.The rate of diazepam N-demethylation was about one-third that of 3-hydoxylation at a high substrate concentration(0.2mM), however, the rate of N-demethylation increases with the decrease in the substrate concentration (-0.02mM).Diazepam N-demethylation seems to be mediated by CYP2C forms.On the other hand, diazepam 3-hydroxylation was selectively catalyzed by CYP3A forms.These results were consistent with the observation in vivo that diazepam N-demethylation and S-mephenytoin 4'-hydroxylation are closely correlated in humans.
Mephenytoin被给七名健康的日本志愿者,这些志愿者被表现为广泛的(EM)和不良的代谢剂(PM)4'-羟基化的代谢物(PM)。六个受试者被判断为EM,其中一个被视为PM.Tewelve Liver Liver Microsomal samples of。还通过测量R和s-甲状腺4'-羟基化来表型EM和PM样品。九种日语和五个高加索受试者被判断为EM,三个日语是PM.基因组DNA。分析了和DNA序列,并在EM和PM之间比较了假定的甲苯二酮4'-羟化酶(CYP2C形式)的序列。 CYP2C19的外显子4在PM中,体内表型。在pM中CYP2C19的外显子5之前的内含子4序列中检测到其他突变,在PM肝脏中均未表达CYP2C19的表型。通过使用从EM和PM获得的肝微粒体进行体外研究的。地西epam n-甲基化的速率约为高基质浓度下3-羟基化的三分之一,但是,N-甲基化的速率随着N-甲基化的速率随着N-甲基化的速率增加而增加。底物浓度(-0.02mm)的降低。Diazepamn-甲基化似乎是由CYP2C形式介导的。另一方面,地西epam 3-羟基化通过CYP3A形式选择性地催化这些结果。地西epam n-甲基化和s-甲基苯二甲基4'-羟基化在人类中密切相关。
项目成果
期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
加藤隆一: "薬物の臨床用量と反復投与毒性試験における無毒性量および体内動態との関連." 臨床薬理. 24. 595-602 (1993)
Ryuichi Kato:“重复剂量毒性研究中临床剂量与未观察到的不良反应水平和药代动力学之间的关系。”24. 595-602 (1993)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
R.Kato: "Molecular pharmacology of drug metabolism." Asian Med.J.3. 59-70 (1994)
R.Kato:“药物代谢的分子药理学”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Yasumori: "Lack of low Km diazepam N-demethylase in liver of poor metabolizers for S-mephenytoin 4'-hydroxylation." Pharmacogenetics. 4. 323-331 (1994)
T.Yasumori:“S-美芬妥英 4-羟基化代谢不良者的肝脏中缺乏低 Km 地西泮 N-去甲基酶。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
L.Chen: "Hepatic microsomal tolbutamide hydroxylation in Japanese : in vitro evidence for rapid and slow metabolizers." Pharmacogenetics. 3. 77-85 (1993)
L.Chen:“日语中的肝微粒体甲苯磺丁脲羟基化:快速和慢速代谢者的体外证据。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
山添 康,他: "ジアゼパムの代謝に関与するチトクロームP450のヒトとラットの比較" 臨床薬理. 25. 161-162 (1994)
Yasushi Yamazoe 等人:“人与大鼠之间参与地西泮代谢的细胞色素 P450 的比较”临床药理学 25. 161-162 (1994)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATO Ryuichi其他文献
KATO Ryuichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATO Ryuichi', 18)}}的其他基金
Crystallography of membrane protein complex by S-SAD method
通过 S-SAD 方法进行膜蛋白复合物的晶体学分析
- 批准号:
15K14468 - 财政年份:2015
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Structural and functional study of enzymes which are related to central nervous system disorders with muscle deficiency
与肌肉缺乏的中枢神经系统疾病相关的酶的结构和功能研究
- 批准号:
20370053 - 财政年份:2008
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of high sensitive Salmonella tester strains expressing mammalian acetvltransferase and sulfotransferase
表达哺乳动物乙酰转移酶和磺基转移酶的高灵敏沙门氏菌测试菌株的建立
- 批准号:
05557120 - 财政年份:1993
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Assessment of human drug metabolism by expression of cytochrome P-450 in yeasts.
通过酵母中细胞色素 P-450 的表达评估人类药物代谢。
- 批准号:
03557113 - 财政年份:1991
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Regulation of expression of cytochrome P-450 by hormonal factor in primary cultured rat hepatocytes.
原代培养大鼠肝细胞中激素因子对细胞色素 P-450 表达的调节。
- 批准号:
02404025 - 财政年份:1990
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for General Scientific Research (A)
Simultaneous Monitoring of Intracellular Calcium Concentration and Catecholamine Release from Superfused PC 12 Cells and Adrenal Chromaffin Cells Cultured on Microcarrier Beads.
同时监测微载体珠上培养的灌流 PC 12 细胞和肾上腺嗜铬细胞的细胞内钙浓度和儿茶酚胺释放。
- 批准号:
01870011 - 财政年份:1989
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B).
Menbrane phospholipase c activation and signal transduction in relation to change of receptor-linkage mechanism
膜磷脂酶 c 激活和信号转导与受体连接机制变化的关系
- 批准号:
62480123 - 财政年份:1987
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Production of human liver cytochrome P-450 by using a biotechnological method and development of the clinical application
生物技术方法生产人肝细胞色素P-450及其临床应用进展
- 批准号:
60870095 - 财政年份:1985
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research
Molecular mechanism of development and regulation of sex-specific cytochrome P-450 in rat liver
大鼠肝脏性别特异性细胞色素P-450发育和调控的分子机制
- 批准号:
59440027 - 财政年份:1985
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for General Scientific Research (A)
相似国自然基金
基于药物代谢组学和基因型的环孢素A药动学个体差异研究
- 批准号:81503175
- 批准年份:2015
- 资助金额:17.9 万元
- 项目类别:青年科学基金项目
人肝微粒体CYP代谢药物个体差异技术平台的建立及关键基础研究
- 批准号:81473279
- 批准年份:2014
- 资助金额:70.0 万元
- 项目类别:面上项目
ADMA关键代谢酶基因多态性与辛伐他汀心血管保护作用个体差异及机制研究
- 批准号:81373489
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
核受体及其靶基因CYPs的基因多态性对青蒿素类药物代谢调控的分子机制研究
- 批准号:81373483
- 批准年份:2013
- 资助金额:65.0 万元
- 项目类别:面上项目
CNI介导免疫细胞STAT5/STAT3调节失衡与药物代谢相关CYP3A/ABCB1基因个体差异致移植受者炎性肾损伤机制研究
- 批准号:81273256
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
相似海外基金
Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis
恶变前乳腺组织环境中肠道微生物介导的差异增强了早期乳腺肿瘤转移
- 批准号:
10594667 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别:
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
- 批准号:
10354185 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别:
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
- 批准号:
10367805 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别:
Epigenetically regulated stemness program and stem cell niche as targets in pediatric DIPG
表观遗传调控的干细胞程序和干细胞生态位作为儿科 DIPG 的目标
- 批准号:
10635435 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别:
A novel peptide assay for hepcidin clinical monitoring
一种用于铁调素临床监测的新型肽测定方法
- 批准号:
10698746 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别: